4.7 Article

Chlamydial Protease-Like Activity Factor and Type III Secreted Effectors Cooperate in Inhibition of p65 Nuclear Translocation

期刊

MBIO
卷 7, 期 5, 页码 -

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/mBio.01427-16

关键词

-

资金

  1. HHS \ National Institutes of Health (NIH)

向作者/读者索取更多资源

The chlamydial protease-like activity factor (CPAF) is hypothesized to be an important secreted virulence factor; however, challenges in denaturing its proteolytic activity have hampered attempts to identify its legitimate targets. Here, we use a genetic and proteomic approach to identify authentic CPAF targets. Human epithelial cells infected with CPAF-sufficient and CPAF-deficient chlamydiae were lysed using known CPAF-denaturing conditions. Their protein profiles were analyzed using isobaric mass tags and liquid chromatography-tandem mass spectrometry. Comparative analysis of CPAF-sufficient and CPAF-deficient infections identified a limited number of CPAF host and chlamydial protein targets. Host targets were primarily interferon-stimulated gene products, whereas chlamydial targets were type III secreted proteins. We provide evidence supporting a cooperative role for CPAF and type III secreted effectors in blocking NF-kappa B p65 nuclear translocation, resulting in decreased beta interferon and proinflammatory cytokine synthesis. Genetic complementation of null organisms with CPAF restored p65 nuclear translocation inhibition and proteolysis of chlamydial type III secreted effector proteins (T3SEs). We propose that CPAF and T3SEs cooperate in the inhibition of host innate immunity. IMPORTANCE Chlamydia trachomatis is an important human pathogen responsible for over 100 million infections each year worldwide. Its success as an intracellular pathogen revolves around its ability to evade host immunity. The chlamydial protease-like activity factor (CPAF) is a conserved serine protease secreted into the host cytosol of infected cells that is thought to play an important role in immune evasion. Currently, CPAF's authentic in situ target(s) and mechanism of action in immune evasion are poorly characterized. Using a CPAF-deficient strain and high-throughput proteomics, we report novel CPAF host and chlamydial targets. Host targets were primarily interferon-stimulated genes, whereas chlamydial targets were exclusively type III secreted proteins. We propose a novel mechanism for CPAF and type III secreted proteins in the evasion of host innate immune responses. These findings provide new insights into CPAF's function as a virulence factor and a better understanding of how chlamydiae evade host immunity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Biochemistry & Molecular Biology

Extendable and explainable deep learning for pan-cancer radiogenomics research

Qian Liu, Pingzhao Hu

Summary: Radiogenomics is a field that combines medical images and genomic analysis to address important clinical questions. This review provides an overview of the current state, limitations, and potential future directions of deep learning in pan-cancer radiogenomic research, while also briefly discussing traditional machine learning methods and research resources. The extendibility and explainability of deep learning in pan-cancer radiogenomics are emphasized.

CURRENT OPINION IN CHEMICAL BIOLOGY (2022)

Article Medicine, Research & Experimental

Polygenic risk and causal inference of psychiatric comorbidity in inflammatory bowel disease among patients with European ancestry

Yao Li, Charles N. Bernstein, Wei Xu, Pingzhao Hu

Summary: This study evaluated the contribution of genetic variants to psychiatric comorbidities among persons with inflammatory bowel disease (IBD) and found that the expression level of the RBPMS gene acts as a mediator. The polygenic risk score (PRS) could be potentially used for PC risk screening in IBD patients.

JOURNAL OF TRANSLATIONAL MEDICINE (2022)

Article Biochemical Research Methods

Tightly integrated multiomics-based deep tensor survival model for time-to-event prediction

Jasper Zhongyuan Zhang, Wei Xu, Pingzhao Hu

Summary: This study aims to develop a new deep learning-based algorithm that integrates multiple high-dimensional omics data to improve cancer survival outcome prediction. The algorithm was applied to breast cancer and colon and rectal cancer data, and demonstrated better performance in survival prediction compared to other omics-based and genomic-based algorithms, as well as conventional data integration methods.

BIOINFORMATICS (2022)

Article Biochemical Research Methods

Deep clustering of small molecules at large-scale via variational autoencoder embedding and K-means

Hamid Hadipour, Chengyou Liu, Rebecca Davis, Silvia T. Cardona, Pingzhao Hu

Summary: This study developed a novel analytical framework that combines feature engineering for molecule-specific atomic and bonding features with a deep learning-based embedding strategy for different molecular features. By applying these embeddings, successful clustering of a large molecule dataset was achieved, showing the potential for optimizing drug discovery.

BMC BIOINFORMATICS (2022)

Article Computer Science, Interdisciplinary Applications

YOLO-LOGO: A transformer-based YOLO segmentation model for breast mass detection and segmentation in digital mammograms

Yongye Su, Qian Liu, Wentao Xie, Pingzhao Hu

Summary: This study proposes a deep learning model for breast cancer mass detection and segmentation using mammography. The model performs significantly better than previous works, achieving high accuracy in mass detection and segmentation. It has the potential to assist doctors in early breast cancer detection and treatment, reducing mortality.

COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2022)

Article Chemistry, Multidisciplinary

Deep learning-driven prediction of drug mechanism of action from large-scale chemical-genetic interaction profiles

Chengyou Liu, Andrew M. Hogan, Hunter Sturm, Mohd Wasif Khan, Md. Mohaiminul Islam, A. S. M. Zisanur Rahman, Rebecca Davis, Silvia T. Cardona, Pingzhao Hu

Summary: This study proposes a comprehensive framework based on graph-based deep learning models for predicting chemical-genetic interaction profiles (CGIPs) and generating hypotheses about the mechanism of action of new drugs. By matching genes and using neural network models for prediction, we successfully created gene clusters in Mycobacterium tuberculosis and accurately predicted activity against essential targets for this disease.

JOURNAL OF CHEMINFORMATICS (2022)

Article Biochemical Research Methods

Semi-supervised COVID-19 CT image segmentation using deep generative models

Judah Zammit, Daryl L. X. Fung, Qian Liu, Carson Kai-Sang Leung, Pingzhao Hu

Summary: This study proposes a novel model that combines the image segmentation abilities of deep convolution networks and the semi-supervised learning abilities of generative models for chest CT images of COVID-19 patients. Comparing it to other segmentation models, the results show that the proposed model has comparable performance and appealing advantages.

BMC BIOINFORMATICS (2022)

Article Biochemistry & Molecular Biology

Plasma Microbiome in COVID-19 Subjects: An Indicator of Gut Barrier Defects and Dysbiosis

Ram Prasad, Michael John Patton, Jason Levi. Floyd, Seth Fortmann, Mariana DuPont, Angela Harbour, Justin Wright, Regina Lamendella, Bruce R. Stevens, Gavin Y. Oudit, Maria B. Grant

Summary: This study aimed to investigate whether plasma analysis could provide insight into gut barrier dysfunction in patients with COVID-19 infection. The findings showed significant dysbiosis of the plasma microbiome in COVID-19 patients, along with increased abundance of Actinobacteria species and decreased abundance of Bacteroides species. Moreover, the concentration of gut permeability markers was significantly elevated in COVID-19 patients compared to healthy individuals. These findings suggest that the gut may contribute to worsening COVID-19 outcomes and targeting the gut could be a potential strategy for improving patient outcomes.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemical Research Methods

A machine learning model trained on a high-throughput antibacterial screen increases the hit rate of drug discovery

A. S. M. Zisanur Rahman, Chengyou Liu, Hunter Sturm, Andrew M. Hogan, Rebecca Davis, Pingzhao Hu, Silvia T. Cardona

Summary: Machine learning was used to predict the antibacterial activity of compounds, resulting in the discovery of potential antibacterial compounds through virtual screening. The hit rate of the predicted compounds was significantly improved, indicating the effectiveness of this approach in increasing the hit rate of drug discovery.

PLOS COMPUTATIONAL BIOLOGY (2022)

Article Biochemistry & Molecular Biology

Association between Downstream Taste Signaling Genes, Oral Microbiome, and Severe Early Childhood Caries

Vivianne Cruz de Jesus, Betty-Anne Mittermuller, Pingzhao Hu, Robert J. Schroth, Prashen Chelikani

Summary: This study aimed to evaluate associations between severe early childhood caries (S-ECC), the oral microbiome, and variants in genes involved in taste sensation. Results showed significant associations between three loci in the PLCB2 gene and S-ECC, as well as associations between variants in other genes and dental biofilm composition. These findings contribute to our understanding of the role of genetics in S-ECC.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Genetics & Heredity

Bioinformatics driven discovery of small molecule compounds that modulate the FOXM1 and PPARA pathway activities in breast cancer

Shujun Huang, Pingzhao Hu, Ted M. Lakowski

Summary: In this study, we identified small molecule compounds that could modulate the PPARA and FOXM1 pathways in breast cancer. Through two different methods, we found 19 compounds that could decrease the activity of the FOXM1 pathway and 13 compounds that could increase the activity of the PPARA pathway. Further experimental validation of these compounds may provide insights into their effects on triple negative breast cancer.

PHARMACOGENOMICS JOURNAL (2023)

Article Hematology

Circulating SARS-CoV-2+megakaryocytes are associated with severe viral infection in COVID-19

Seth D. Fortmann, Michael J. Patton, Blake F. Frey, Jennifer L. Tipper, Sivani B. Reddy, Cristiano P. Vieira, Vidya Sagar Hanumanthu, Sarah Sterrett, Jason L. Floyd, Ram Prasad, Jeremy D. Zucker, Andrew B. Crouse, Forest Huls, Rati Chkheidze, Peng Li, Nathaniel B. Erdmann, Kevin S. Harrod, Amit Gaggar, Paul A. Goepfert, Maria B. Grant, Matthew Might

Summary: Multiple lines of evidence suggest that the dysfunction of megakaryocytes is present in severe cases of COVID-19. This study characterized the peripheral circulating megakaryocytes in a large cohort of COVID-19 inpatients and found that megakaryocytes were increased in the bloodstream of COVID-19 patients. The presence of S100A8/A9 was identified as a marker for megakaryocyte dysfunction. It was also discovered that there was a subpopulation of S100A8/A9+ megakaryocytes containing SARS-CoV-2 proteins and RNA. These findings suggest the role of megakaryocytes in the pathogenesis of severe COVID-19 and their potential as a risk factor for mortality and organ injury.

BLOOD ADVANCES (2023)

Article Biochemistry & Molecular Biology

Development and validation of a prognostic 15-gene signature for stratifying HER2+/ER+ breast cancer

Qian Liu, Shujun Huang, Danielle Desautels, Kirk J. McManus, Leigh Murphy, Pingzhao Hu

Summary: This study identified two distinct subgroups within HER2+/ER+ breast cancer using gene expression data. These subgroups showed differences in survival outcomes, drug response, and other characteristics. A classification model using a 15-gene signature achieved strong predictive performance. These findings provide insights into the molecular diversity of HER2+/ER+ breast cancer and may guide the development of precision therapies.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2023)

Article Critical Care Medicine

COVID-19 bacteremic co-infection is a major risk factor for mortality, ICU admission, and mechanical ventilation

Michael John Patton, Carlos J. Orihuela, Kevin S. Harrod, Mohammad A. N. Bhuiyan, Paari Dominic, Christopher G. Kevil, Daniel Fort, Vincent X. X. Liu, Maha Farhat, Jonathan L. Koff, Charitharth V. Lal, Anuj Gaggar, Robert P. Richter, Nathaniel Erdmann, Matthew Might, Amit Gaggar

Summary: A large retrospective study found that community-acquired bacterial co-infection related to COVID-19 is a significant factor contributing to mortality, with a higher mortality rate compared to community-acquired bacteremia. An elevated neutrophil-to-lymphocyte ratio above 15 is a prognostic indicator of COVID-19 bacterial co-infection.

CRITICAL CARE (2023)

Article Computer Science, Artificial Intelligence

The precision medicine process for treating rare disease using the artificial intelligence tool mediKanren

Aleksandra Foksinska, Camerron M. Crowder, Andrew B. Crouse, Jeff Henrikson, William E. Byrd, Gregory Rosenblatt, Michael J. Patton, Kaiwen He, Thi K. Tran-Nguyen, Marissa Zheng, Stephen A. Ramsey, Nada Amin, John Osborne, Matthew Might

Summary: There are over 6,000 different rare diseases estimated to impact 300 million people worldwide. Identifying treatments for these disorders is challenging due to a limited understanding of disease mechanisms, interindividual symptom variability, and little commercial incentive to develop new treatments. To address these challenges, The Hugh Kaul Precision Medicine Institute developed an artificial intelligence tool, mediKanren, that leverages the mechanistic insight of genetic disorders to identify therapeutic options.

FRONTIERS IN ARTIFICIAL INTELLIGENCE (2022)

暂无数据